Fidson Healthcare Plc has secured shareholder approval for a dividend payout of ₦3.6 billion, marking a significant return of capital to investors.
The distribution, set at ₦1.50 per 50 kobo ordinary share, follows a robust first half of 2026 that demonstrated the company's financial resilience amid a challenging macroeconomic environment in Nigeria.
The payout underscores management's confidence in the firm's cash generation capabilities and its strategic trajectory.
Fidson, widely recognized as Nigeria's largest pharmaceutical manufacturer, is using this capital return to signal stability while simultaneously pursuing an aggressive growth agenda.
The company has repeatedly stated its ambition to become the largest pharmaceutical manufacturer on the African continent, a goal that requires sustained investment in production capacity and distribution networks.
This dividend declaration comes on the heels of strong operational performance in the first six months of 2026.